FRAX® is an algorithm that computes 10-year probability of hip fracture and major osteoporotic fractures (hip, humerus, wrist fractures and clinical vertebral fractures) in patients aged 40 years and older. These probabilities are calculated based on age, body mass index and several clinical risk factors with or without the inclusion of bone mineral density at the femoral neck. Today, FRAX algorithm is included in most European and American recommendations for the prevention and treatment of osteoporosis. This article describes the results of the development and adaptation of a Ukrainian model of FRAX. In June 2016, this questionnaire became available in Ukrainian language thanks to the staff of Ukrainian Scientific-Medical Center of Osteoporosis and SI «Institute of Gerontology named after D.F. Chebotarev of NAMS Ukraine». In October 2016, thanks to the authors of this article, Ukrainian model was launched on the official FRAX website. This model was created on the basis of some epidemiological studies conducted in recent years by the members of the Ukrainian Association of Osteoporosis and Ukrainian-Scientific Medical Center of Osteoporosis supported by Ukrainian Association of Traumatologists and Orthopedists (particularly, in Vinnytsia (1997–2002) and Uzhhorod, and Vinnytsia region (STOP study, 2011–2012)). Ukrainian model of FRAX is the first domestic model of 10-year probability prediction, with risk of major osteoporotic fracture and hip fracture in mind. It was created using the original FRAX methodology, which was developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases. Its development provides the opportunity for its broad implementation in clinical practice.

10-year fracture probability; FRAX; osteoporotic fractures; hip fracture; osteoporosis; risk factors

Поворознюк В.В. Захворювання кістково-м’язової системи в людей різного віку (вибрані лекції, огляди, статті): У 3 т. — ​К., 2009. — 664 c.

Kanis J.A., Borgström F., Compston J. et al. SCOPE: a scorecard for osteoporosis in Europe // Arch. Osteoporos. — 2013. — 8. — ​P. 144.

Hernlund E., Svedbom A., Ivergård M. et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) // Arch. Osteoporos. — 2013. — 8. — ​P. 136. — ​dоі: 10.1007/s11657-013-0136-1.

Поворознюк В.В., Григорьева Н.В., Орлик Т.В. и др. Остеопороз в практике врача-интерниста. — ​К., 2014. — 198 с.

Kanis J.A. World Health Organization Scientific Group Assessment of osteoporosis at the primary health-care level. Technical report. WHO Collaborating Centre, University of Sheffield, UK, 2008 // http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf. — ​Oct. 2016. — ​Accessed 31.

Kanis J.A., Oden A., Johnell O. et al. The use of clinical risk factors enhances the performance of МЩКТ in the prediction of hip and osteoporotic fractures in men and women // Osteoporos. Int. — 2007. — 18. — ​Р. 1033-1046.

McCloskey E.V., Harvey N.C., Johansson H., Kanis J.A. FRAX updates 2016 // Curr. Opin. Rheumatol. — 2016. — 28(4). — ​P. 433-441. — ​doi: 10.1097/BOR.0000000000000304.

Kanis J.A., Harvey N.C., Cooper C. et al., Advisory Board of the National Osteoporosis Guideline Group. A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation // Arch. Osteoporos. — 2016. — 11(1). — ​Р. 25. — ​doi: 10.1007/s11657-016-0278-z.

Camacho P.M., Petak S.M., Binkley N. et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis — ​2016. Executive Summary // Endocr. Pract. — 2016. — 22(9). — ​Р. 1111-1118. — ​doi: 10.4158/EP161435.ESGL.

Kanis J.A., McCloskey E.V., Johansson H. et al. on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) European guidance for the diagnosis and management of osteoporosis in postmenopausal women // Osteoporos. Int. — 2013. — 24. — ​Р. 23-57. — ​doi: 10.1007/s00198-012-2074-y.

Cauley J.A., El-Hajj Fuleihan G., Arabi A. et al. Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® // J. Clin. Densitom. — 2011. — 14. — ​Р. 240-262.

Поворознюк В.В., Григорьева Н.В. Роль FRAX в прогнозировании риска переломов // Новости медицины и фармации. — 2011. — 16(379). — ​http://www.mif-ua.com/archive/article/21687

Поворознюк В.В., Григорьева Н.В. Информативность различных моделей FRAX в оценке риска остеопоротических переломов у женщин Украины // Боль. Суставы. Позвоночник. — 2013. — 2. — ​http://cyberleninka.ru/article/n/informativnost-razlichnyh-modeley-frax-v-otsenke-riska-osteoporoticheskih-perelomov-u-zhenschin-ukrainy

Поворознюк В.В., Григорьева Н.В. Оценка возможностей использования австрийской модели FRAX в прогнозировании риска остеопоротических переломов у украинских женщин // Боль. Суставы. Позвоночник. — 2013. — 3. — ​http://www.mif-ua.com/archive/article/37586

Povoroznyuk V.V., Grygorieva N.V., Kanis J.A., McCloskey E.V., Johansson H., Korzh M.O., Strafun S.S., Vaida V.M., Klymovytsky F.V., Vlasenko R.O., Forosenko V.S. Epidemiology of osteoporotic fractures in Ukraine: results of two retrospective studies // Osteoporosis international (подано до друку).

Поворознюк В.В., Григор’єва Н.В., Корж М.О., Страфун С.С., Вайда В.М., Климовицький Ф.В., Власенко Р.О., Kanis J.A., Johansson H., McCloskey E.V. Епідеміологія переломів стегнової кістки в Україні: результати дослідження СТОП // Травма (подано до друку).

Grigorie D., Sucaliuc A., Johansson H. et al. Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model // Calcif. Tissue Int. — 2012. — 92(5). — ​Р. 429-436. — ​doi: 10.1007/s00223-013-9697-7.

Badurski J.E., Kanis J.A., Johansson H. et al. The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland // Pol. Arch. Med. Wewn. — 2011. — 121(5). — ​Р. 148-155.

Stepan J.J., Vaculik J., Pavelka K. et al. Hip Fracture Incidence from 1981 to 2009 in the Czech Republic as a Basis of the Country-Specific FRAX Model // Calcif. Tissue Int. — 2012. — 90(5). — ​Р. 365-372.

Péntek M., Gulácsi L., Tóth E. et al. Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary // Orv. Hetil. — 2016. — 157(4). — ​Р. 146-153. — ​doi: 10.1556/650.2015.30347.

Johansson H., Kanis J.A., McCloskey E.V. et al. A FRAX model for the assessment of fracture probability in Belgium // Osteoporos. Int. — 2010. — 22. — ​Р. 453-461.

Papaioannou A., Morin S., Cheung A.M. et al. Scientific Advisory Council of Osteoporosis Canada 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary // CMAJ. — 2010. — 182. — ​Р. 1864-1873.

Kanis J.A., McCloskey E.V., Johansson H. et al. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) European guidance for the diagnosis and management of osteoporosis in postmenopausal women // Osteoporos. Int. — 2013. — 24. — ​Р. 23-57.

Lekawasam S., Adachi J.D., Agnusdei D. et al. GIO IOF-ECTS, Guidelines Working Group A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis // Osteoporos. Int. — 2012. — 23. — ​Р. 2257-2276.

Committee of Japanese Guidelines for the Prevention and Treatment of Osteoporosis. The Japanese guidelines for the prevention and treatment of osteoporosis (2011 edition) // Life Science. — 2012. — ​Japanese рublishing (Tokyo).

Compston J., Cooper A., Cooper C. et al. National Osteoporosis Guideline Group (NOGG) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK // Maturitas. — 2009. — 62. — ​Р. 105-108.

Grossman J.M., Gordon R., Ranganath V.K. et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis // Arthritis Care Res. (Hoboken). — 2010. — 62. — ​Р. 15-26.

Dawson-Hughes B., National Osteoporosis Foundation Guide Committee. A revised clinician’s guide to the prevention and treatment of osteoporosis // J. Clin. Endocrinol. Metab. — 2008. — 93. — ​P. 2463-2465.